Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022 Featured Updates to the NCCN Guidelines

被引：53

作者：

Wierda, William G. ^{[1
]}

Brown, Jennifer ^{[2
]}

Abramson, Jeremy S. ^{[3
]}

Awan, Farrukh ^{[4
]}

Bilgrami, Syed F. ^{[5
]}

Bociek, Greg ^{[6
]}

Brander, Danielle ^{[7
]}

Chanan-Khan, Asher A. ^{[8
]}

Coutre, Steve E. ^{[9
]}

Davis, Randall S. ^{[10
]}

Eradat, Herbert ^{[11
]}

Fletcher, Christopher D. ^{[12
]}

Gaballa, Sameh ^{[13
]}

Ghobadi, Armin ^{[14
,15
]}

Hamid, Muhammad Saad ^{[16
]}

Hernandez-Ilizaliturri, Francisco ^{[17
]}

Hill, Brian ^{[18
,19
]}

Kaesberg, Paul ^{[20
]}

Kamdar, Manali ^{[21
]}

Kaplan, Lawrence D. ^{[22
]}

Khan, Nadia ^{[23
]}

Kipps, Thomas J. ^{[24
]}

Ma, Shuo ^{[25
]}

Mato, Anthony ^{[26
]}

Mosse, Claudio ^{[27
]}

Schuster, Stephen ^{[28
]}

Siddiqi, Tanya ^{[29
]}

Stephens, Deborah M. ^{[30
]}

Ujjani, Chaitra ^{[31
]}

Wagner-Johnston, Nina ^{[32
]}

Woyach, Jennifer A. ^{[33
]}

Ye, J. Christine ^{[34
]}

Dwyer, Mary A. ^{[35
]}

Sundar, Hema ^{[35
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[3] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[4] UT Southwestern Simmons Comprehens Canc Ctr, Dallas, TX USA

[5] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[6] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[7] Duke Canc Inst, Durham, NC USA

[8] Mayo Clin, Canc Ctr, Rochester, MN USA

[9] Stanford Canc Inst, Stanford, CA USA

[10] ONeal Comprehens Canc Ctr UAB, Birmingham, AL USA

[11] UCLA, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA

[12] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[13] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[14] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO 63110 USA

[15] Washington Univ, Sch Med, St Louis, MO USA

[16] Univ Tennessee, Hlth Sci Ctr, St Jude Chidrens Res Hosp, Knoxville, TN 37996 USA

[17] Roswel Pk Comprehens Canc Ctr, Buffalo, NY USA

[18] Univ Hosp Seidman Canc Ctr, Case Comprehensve Canc Ctr, Cleveland, OH USA

[19] Cleveland Clin, Tausslg Canc Inst, Cleveland, OH 44106 USA

[20] UC Davis Comprehens Canc Ctr, Davis, CA USA

[21] Univ Colorado, Canc Ctr, Boulder, CO 80309 USA

[22] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[23] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[24] UC San Diego Moores Canc Ctr, San Diego, CA USA

[25] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[26] Mem Sloan Kettering Canc Ctr, Ithaca, NY USA

[27] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[28] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[29] City Hope Natl Med Ctr, Duarte, CA USA

[30] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[31] Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, 1124 Columbia St, Seattle, WA 98104 USA

[32] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[33] Ohio State Univ, Comprehenslve Canc Ctr, James Canc Hosp & Solove Res Inst, Columbus, OH 43210 USA

[34] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[35] Natl Comprehens Canc Network, Philadelphia, PA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2022年 / 20卷 / 06期

关键词：

MINIMAL RESIDUAL DISEASE; CHLORAMBUCIL PLUS OBINUTUZUMAB; FLOW-CYTOMETRY; OPEN-LABEL; 1ST-LINE TREATMENT; FOLLOW-UP; PHASE-II; IBRUTINIB; VENETOCLAX; CLL;

D O I：

10.6004/jnccn.2022.0031

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The treatment landscape of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) has significantly evolved in recent years. Targeted therapy with Bruton???s tyrosine kinase (BTK) inhibitors and BCL-2 inhibitors has emerged as an effective chemotherapy-free option for patients with previously untreated or relapsed/refractory CLL/SLL. Undetectable minimal residual disease after the end of treatment is emerging as an important predictor of progression-free and overall survival for patients treated with fixed-duration BCL-2 inhibitor-based treatment. These NCCN Guidelines Insights discuss the updates to the NCCN Guidelines for CLL/ SLL specific to the use of chemotherapy-free treatment options for patients with treatment-na??ve and relapsed/refractory disease.

引用

页码：622 / 634

页数：13

共 50 条

[31] Melanoma: Cutaneous, Version 2.2024 Featured Updates to the NCCN Guidelines
Swetter, Susan M.
Johnson, Douglas
Albertini, Mark R.
Barker, Christopher A.
Bateni, Sarah
Baumgartner, Joel
Bhatia, Shailender
Bichakjian, Christopher
Boland, Genevieve
Chandra, Sunandana
Chmielowski, Bartosz
Dimaio, Dominick
Dronca, Roxana
Fields, Ryan C.
Fleming, Martin D.
Galan, Anjela
Guild, Samantha
Hyngstrom, John
Karakousis, Giorgos
Kendra, Kari
Kiuru, Maija
Lange, Julie R.
Lanning, Ryan
Logan, Theodore
Olson, Daniel
Olszanski, Anthony J.
Ott, Patrick A.
Ross, Merrick I.
Rothermel, Luke
Salama, April K.
Sharma, Rohit
Skitzki, Joseph
Smith, Emily
Tsai, Katy
Wuthrick, Evan
Xing, Yan
McMillian, Nicole
Espinosa, Sara
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (05): : 290 - 298
[32] Multiple Myeloma, Version 1.2013 Featured Updates to the NCCN Guidelines
Anderson, Kenneth C.
Alsina, Melissa
Bensinger, William
Biermann, J. Sybil
Cohen, Adam D.
Devine, Steven
Djulbegovic, Benjamin
Faber, Edward A., Jr.
Gasparetto, Cristina
Hernandez-Illizaliturri, Francisco
Huff, Carol Ann
Kassim, Adetola
Krishnan, Amrita Y.
Liedtke, Michael
Meredith, Ruby
Raje, Noopur
Schriber, Jeffrey
Singhal, Seema
Somlo, George
Stockerl-Goldstein, Keith
Treon, Steven P.
Weber, Donna
Yahalom, Joachim
Yunus, Furhan
Shead, Dorothy A.
Kumar, Rashmi
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (01): : 11 - 17
[33] Bladder Cancer, Version 2.2022 Featured Updates to the NCCN Guidelines
Flaig, Thomas W.
Spiess, Philippe E.
Abern, Michael
Agarwal, Neeraj
Bangs, Rick
Boorjian, Stephen A.
Buyyounouski, Mark K.
Chan, Kevin
Chang, Sam
Friedlander, Terence
Greenberg, Richard E.
Guru, Khurshid A.
Herr, Harry W.
Hoffman-Censits, Jean
Kishan, Amar
Kundu, Shilajit
Lele, Subodh M.
Mamtani, Ronac
Margulis, Vitaly
Mian, Omar Y.
Michalski, Jeff
Montgomery, Jeffrey S.
Nandagopal, Lakshminarayanan
Pagliaro, Lance C.
Parikh, Mamta
Patterson, Anthony
Plimack, Elizabeth R.
Pohar, Kamal S.
Preston, Mark A.
Richards, Kyle
Sexton, Wade J.
Siefker-Radtke, Arlene O.
Tollefson, Matthew
Tward, Jonathan
Wright, Jonathan L.
Dwyer, Mary A.
Cassara, Carly J.
Gurski, Lisa A.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (08): : 866 - 878
[34] Rectal Cancer, Version 3.2024 Featured Updates to the NCCN Guidelines
Benson III, Al B.
Venook, Alan P.
Adam, Mohamed
Chang, George
Chen, Yi-Jen
Ciombor, Kristen K.
Cohen, Stacey A.
Cooper, Harry S.
Deming, Dustin
Garrido-Laguna, Ignacio
Grem, Jean L.
Haste, Paul
Hecht, J. Randolph
Hoffe, Sarah
Hunt, Steven
Hussan, Hisham
Johung, Kimberly L.
Joseph, Nora
Kirilcuk, Natalie
Krishnamurthi, Smitha
Malla, Midhun
Maratt, Jennifer K.
Messersmith, Wells A.
Meyerhardt, Jeffrey
Miller, Eric D.
Mulcahy, Mary F.
Nurkin, Steven
Parikh, Aparna
Patel, Hitendra
Pedersen, Katrina
Saltz, Leonard
Schneider, Charles
Shibata, David
Shogan, Benjamin
Skibber, John M.
Sofocleous, Constantinos T.
Tavakkoli, Anna
Willett, Christopher G.
Wu, Christina
Jones, Frankie
Gurski, Lisa
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (06): : 366 - 375
[35] NCCN Guidelines® Insights Non- Small Cell Lung Cancer, Version 5.2018 Featured Updates to the NCCN Guidelines
Ettinger, David S.
Aisner, Dara L.
Wood, Douglas E.
Akerley, Wallace
Bauman, Jessica
Chang, Joe Y.
Chirieac, Lucian R.
D'Amico, Thomas A.
Dilling, Thomas J.
Dobelbower, Michael
Govindan, Ramaswamy
Gubens, Matthew A.
Hennon, Mark
Horn, Leora
Lackner, Rudy P.
Lanuti, Michael
Leal, Ticiana A.
Lilenbaum, Rogerio
Lin, Jules
Loo, Billy W., Jr.
Martins, Renato
Otterson, Gregory A.
Sandip, P.
Reckamp, Karen
Riely, Gregory J.
Schild, Steven E.
Shapiro, Theresa A.
Stevenson, James
Swanson, Scott J.
Tauer, Kurt
Yang, Stephen C.
Gregory, Kristina
Hughes, Miranda
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (07): : 807 - 821
[36] Systemic Mastocytosis, Version 3.2024: Featured Updates to the NCCN Guidelines
Gotlib, Jason
Gerds, Aaron T.
Abdelmessieh, Peter
Ali, Haris
Castells, Mariana
Dunbar, Andrew
Revell, Ruth Fein
George, Tracy I.
Green, Steven
Gundabolu, Krishna
Hexner, Elizabeth
Jain, Tania
Jamieson, Catriona
Kaesberg, Paul R.
Kuykendall, Andrew T.
Madanat, Yazan
Manchanda, Naveen
Masarova, Lucia
May, Jori
McMahon, Brandon
Mohan, Sanjay R.
Nadiminti, Kalyan V.
Oh, Stephen
Palmer, Jeanne
Patel, Ami
Patel, Anand A.
Podoltsev, Nikolai
Rein, Lindsay
Salit, Rachel
Talpaz, Moshe
Wadleigh, Martha
Wall, Sarah
Bergman, Mary Anne
Hochstetler, Cindy
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (2D):
[37] Multiple Myeloma, Version 3.2016 Featured Updates to the NCCN Guidelines
Anderson, Kenneth C.
Alsina, Melissa
Atanackovic, Djordje
Biermann, J. Sybil
Chandler, Jason C.
Costello, Caitlin
Djulbegovic, Benjamin
Fung, Henry C.
Gasparetto, Cristina
Godby, Kelly
Hofmeister, Craig
Holmberg, Leona
Holstein, Sarah
Huff, Carol Ann
Kassim, Adetola
Krishnan, Amrita Y.
Kumar, Shaji K.
Liedtke, Michaela
Lunning, Matthew
Raje, Noopur
Reu, Frederic J.
Singhal, Seema
Somlo, George
Stockerl-Goldstein, Keith
Treon, Steven P.
Weber, Donna
Yahalom, Joachim
Shead, Dorothy A.
Kumar, Rashmi
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (04): : 389 - 400
[38] NCCN Guidelines® Insights Neuroendocrine and Adrenal Tumors, Version 2.2018 Featured Updates to the NCCN Guidelines
Shah, Manisha H.
Goldner, Whitney S.
Halfdanarson, Thorvardur R.
Bergsland, Emily
Berlin, Jordan D.
Halperin, Daniel
Chan, Jennifer
Kulke, Matthew H.
Benson, Al B., III
Blaszkowsky, Lawrence S.
Eads, Jennifer
Engstrom, Paul F.
Fanta, Paul
Giordano, Thomas
He, Jin
Heslin, Martin J.
Kalemkerian, Gregory P.
Kandeel, Fouad
Khan, Sajid A.
Kidwai, Wajih Zaheer
Kunz, Pamela L.
Kuvshinoff, Boris W., II
Lieu, Christopher
Pillarisetty, Venu G.
Saltz, Leonard
Sosa, Julie Ann
Strosberg, Jonathan R.
Sussman, Craig A.
Trikalinos, Nikolaos A.
Uboha, Nataliya A.
Whisenant, Jonathan
Wong, Terence
Yao, James C.
Burns, Jennifer L.
Ogba, Ndiya
Zuccarino-Catania, Griselda
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (06): : 693 - 702
[39] NCCN Guidelines® Insights Colorectal Cancer Screening, Version 1.2018 Featured Updates to the NCCN Guidelines
Provenzale, Dawn
Gupta, Samir
Ahnen, Dennis J.
Markowitz, Arnold J.
Chung, Daniel C.
Mayer, Robert J.
Regenbogen, Scott E.
Blanco, Amie M.
Bray, Travis
Cooper, Gregory
Early, Dayna S.
Ford, James M.
Giardiello, Francis M.
Grady, William
Hall, Michael J.
Halverson, Amy L.
Hamilton, Stanley R.
Hampel, Heather
Klapman, Jason B.
Larson, David W.
Lazenby, Audrey J.
Llor, Xavier
Lynch, Patrick M.
Mikkelson, June
Ness, Reid M.
Slavin, Thomas P., Jr.
Sugandha, Shajanpeter
Weiss, Jennifer M.
Dwyer, Mary A.
Ogba, Ndiya
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (08): : 939 - 949
[40] Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies
Rainone, Michael
Siddiqi, Tanya
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2022, 17 (01) : 39 - 45

← 1 2 3 4 5 →